Claim 30% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Integral Diagnostics Ltd. ( (AU:IDX) ) has shared an update.
Integral Diagnostics Limited announced it will hold a group investor conference call on August 26, 2025, following the release of its FY25 results. This event is significant for stakeholders as it provides insights into the company’s financial performance and strategic direction, potentially impacting its market positioning and operations.
The most recent analyst rating on (AU:IDX) stock is a Buy with a A$3.00 price target. To see the full list of analyst forecasts on Integral Diagnostics Ltd. stock, see the AU:IDX Stock Forecast page.
More about Integral Diagnostics Ltd.
Integral Diagnostics (IDX) is a leading provider of medical imaging services in Australia and New Zealand, employing top radiologists and diagnostic imaging specialists. The company focuses on quality patient care and service through a unique medical leadership model.
Average Trading Volume: 1,280,900
Technical Sentiment Signal: Buy
Current Market Cap: A$990.7M
Learn more about IDX stock on TipRanks’ Stock Analysis page.